H.F.L. Mark
-
- Genomic variations and chromosomal abnormalities 17
- BRCA gene mutations in cancer 5
- Genetics and Neurodevelopmental Disorders 3
-
- Cancer Genomics and Diagnostics 4
- Carcinogens and Genotoxicity Assessment 3
-
- Prenatal Screening and Diagnostics 7
-
- Chromosomal and Genetic Variations 6
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- L. Jeffrey MedeirosRoberto N. MirandaEdith Y. WongMarilyn M. BuiMary C. LoweryShuhua YangStuart C. LauchlanDiane L. Persons
- Cited by
- GeneticsOncologyCancer Research
- Journals
- Genetics in Medicine (2 papers)Clinical Genetics (2 papers)Journal of Medical Genetics (2 papers)
- Partner nations
- United StatesPeruGermany
In The Last Decade
H.F.L. Mark
35 papers receiving 355 citations
Peers
Comparison fields: 5 of 66
- Genetics 156
- Oncology 111
- Cancer Research 54
- Hematology 33
- Pediatrics, Perinatology and Child Health 58
Countries citing papers authored by H.F.L. Mark
This map shows the geographic impact of H.F.L. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.F.L. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.F.L. Mark more than expected).
Fields of papers citing papers by H.F.L. Mark
This network shows the impact of papers produced by H.F.L. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.F.L. Mark. The network helps show where H.F.L. Mark may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H.F.L. Mark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 5 | |
| 2 | 2005 | 15 | |
| 3 | Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study. | 2000 | 52 |
| 4 | 2000 | 13 | |
| 5 | 1999 | 16 | |
| 6 | 1999 | 14 | |
| 7 | 1998 | 12 | |
| 8 | 1998 | 8 | |
| 9 | Reproducibility of LSI HER-2/neu SpectrumOrange and CEP 17 SpectrumGreen Dual Color deoxyribonucleic acid probe kit. For enumeration of gene amplification in paraffin-embedded specimens: a multicenter clinical validation study. | 1998 | 26 |
| 10 | A laboratorian's view on the College of American Pathologists' Laboratory Accreditation Program for Clinical Laboratories. | 1998 | 1 |
| 11 | 1997 | 5 | |
| 12 | Emerging molecular cytogenetic technologies. | 1997 | 16 |
| 13 | Clinical and research issues in breast cancer genetics. | 1997 | 5 |
| 14 | Laboratory study of breast cancer using conventional and molecular cytogenetics. | 1996 | 2 |
| 15 | Douglas-fir: a third wood-drying condensate found to exhibit in vitro cytotoxicity and genotoxicity. | 1996 | 1 |
| 16 | Issues in the genetic assessment of predispositions for familial breast and ovarian cancer. | 1996 | 0 |
| 17 | Assessment of sex chromosome composition using fluorescent in situ hybridization as an adjunct to GTG-banding. | 1995 | 9 |
| 18 | Interstitial telomeric sequences in human chromosomes cluster with common fragile sites, mutagen sensitive sites, viral integration sites, cancer breakpoints, proto-oncogenes and breakpoints involved in primate evolution | 1994 | 1 |
| 19 | 1993 | 12 | |
| 20 | Centromere index derivation by a novel and convenient approach. | 1993 | 6 |
About H.F.L. Mark
H.F.L. Mark is a scholar working on Chemical Health and Safety, Genetics, Cancer Research, Pediatrics, Perinatology and Child Health and Otorhinolaryngology, having authored 38 papers that have together received 375 indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (17 papers), Prenatal Screening and Diagnostics (7 papers), Chromosomal and Genetic Variations (6 papers), BRCA gene mutations in cancer (5 papers), Cancer Genomics and Diagnostics (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Genetics and Neurodevelopmental Disorders (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Genetics (156 citations), Oncology (111 citations), Cancer Research (54 citations), Hematology (33 citations) and Pediatrics, Perinatology and Child Health (58 citations). H.F.L. Mark has collaborated with scholars based in United States, Peru and Germany. Frequent co-authors include L. Jeffrey Medeiros, Roberto N. Miranda, Edith Y. Wong, Marilyn M. Bui, Mary C. Lowery, Shuhua Yang, Stuart C. Lauchlan, Diane L. Persons, R Mikumo and L Braun. Their work appears in journals such as Genetics in Medicine, Clinical Genetics, Journal of Medical Genetics, The American Journal of Human Genetics and Annals of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.